Global Glucagon Like Peptide 2 Receptor Market Research Report 2023

The global Glucagon Like Peptide 2 Receptor market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Glucagon Like Peptide 2 Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Glucagon Like Peptide 2 Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Glucagon Like Peptide 2 Receptor include Hanmi Pharmaceuticals Co Ltd, Naia Ltd, Takeda, Tasly Pharmaceutical Group Co Ltd and Zealand Pharma AS, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Glucagon Like Peptide 2 Receptor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon Like Peptide 2 Receptor.

The Glucagon Like Peptide 2 Receptor market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Glucagon Like Peptide 2 Receptor market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Glucagon Like Peptide 2 Receptor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Glucagon Like Peptide 2 Receptor

1.2 Glucagon Like Peptide 2 Receptor Segment by Type

1.2.1 Global Glucagon Like Peptide 2 Receptor Market Value Comparison by Type (2023-2029)

1.2.2 FE-203799

1.2.3 Glepaglutide

1.2.4 GXG-8

1.2.5 HM-15910

1.2.6 Others

1.3 Glucagon Like Peptide 2 Receptor Segment by Application

1.3.1 Global Glucagon Like Peptide 2 Receptor Market Value by Application: (2023-2029)

1.3.2 Short Bowel Syndrome

1.3.3 Diabetes

1.3.4 Diarrhea

1.3.5 Obesity

1.3.6 Others

1.4 Global Glucagon Like Peptide 2 Receptor Market Size Estimates and Forecasts

1.4.1 Global Glucagon Like Peptide 2 Receptor Revenue 2018-2029

1.4.2 Global Glucagon Like Peptide 2 Receptor Sales 2018-2029

1.4.3 Global Glucagon Like Peptide 2 Receptor Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturers (2018-2023)

2.2 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Glucagon Like Peptide 2 Receptor Average Price by Manufacturers (2018-2023)

2.4 Global Glucagon Like Peptide 2 Receptor Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Product Type & Application

2.7 Glucagon Like Peptide 2 Receptor Market Competitive Situation and Trends

2.7.1 Glucagon Like Peptide 2 Receptor Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Glucagon Like Peptide 2 Receptor Players Market Share by Revenue

2.7.3 Global Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Glucagon Like Peptide 2 Receptor Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Glucagon Like Peptide 2 Receptor Global Glucagon Like Peptide 2 Receptor Sales by Region: 2018-2029

3.2.1 Global Glucagon Like Peptide 2 Receptor Sales by Region: 2018-2023

3.2.2 Global Glucagon Like Peptide 2 Receptor Sales by Region: 2024-2029

3.3 Global Glucagon Like Peptide 2 Receptor Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2018-2029

3.3.1 Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2018-2023

3.3.2 Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2024-2029

3.4 North America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country

3.4.1 North America Glucagon Like Peptide 2 Receptor Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Glucagon Like Peptide 2 Receptor Sales by Country (2018-2029)

3.4.3 North America Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country

3.5.1 Europe Glucagon Like Peptide 2 Receptor Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Glucagon Like Peptide 2 Receptor Sales by Country (2018-2029)

3.5.3 Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country

3.6.1 Asia Pacific Glucagon Like Peptide 2 Receptor Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Country (2018-2029)

3.6.3 Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country

3.7.1 Latin America Glucagon Like Peptide 2 Receptor Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2018-2029)

3.7.3 Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country

3.8.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2018-2029)

3.8.3 Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Glucagon Like Peptide 2 Receptor Sales by Type (2018-2029)

4.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Type (2018-2023)

4.1.2 Global Glucagon Like Peptide 2 Receptor Sales by Type (2024-2029)

4.1.3 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2018-2029)

4.2 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2029)

4.2.1 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2023)

4.2.2 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2024-2029)

4.2.3 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2029)

4.3 Global Glucagon Like Peptide 2 Receptor Price by Type (2018-2029)

5.1 Global Glucagon Like Peptide 2 Receptor Sales by Application (2018-2029)

5.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Application (2018-2023)

5.1.2 Global Glucagon Like Peptide 2 Receptor Sales by Application (2024-2029)

5.1.3 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2018-2029)

5.2 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2029)

5.2.1 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2023)

5.2.2 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2024-2029)

5.2.3 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2029)

5.3 Global Glucagon Like Peptide 2 Receptor Price by Application (2018-2029)

6.1 Hanmi Pharmaceuticals Co Ltd

6.1.1 Hanmi Pharmaceuticals Co Ltd Corporation Information

6.1.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview

6.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio

6.1.5 Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates

6.2 Naia Ltd

6.2.1 Naia Ltd Corporation Information

6.2.2 Naia Ltd Description and Business Overview

6.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolio

6.2.5 Naia Ltd Recent Developments/Updates

6.3 Takeda

6.3.1 Takeda Corporation Information

6.3.2 Takeda Description and Business Overview

6.3.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Takeda Glucagon Like Peptide 2 Receptor Product Portfolio

6.3.5 Takeda Recent Developments/Updates

6.4 Tasly Pharmaceutical Group Co Ltd

6.4.1 Tasly Pharmaceutical Group Co Ltd Corporation Information

6.4.2 Tasly Pharmaceutical Group Co Ltd Description and Business Overview

6.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio

6.4.5 Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates

6.5 Zealand Pharma AS

6.5.1 Zealand Pharma AS Corporation Information

6.5.2 Zealand Pharma AS Description and Business Overview

6.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolio

6.5.5 Zealand Pharma AS Recent Developments/Updates

7.1 Glucagon Like Peptide 2 Receptor Industry Chain Analysis

7.2 Glucagon Like Peptide 2 Receptor Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Glucagon Like Peptide 2 Receptor Production Mode & Process

7.4 Glucagon Like Peptide 2 Receptor Sales and Marketing

7.4.1 Glucagon Like Peptide 2 Receptor Sales Channels

7.4.2 Glucagon Like Peptide 2 Receptor Distributors

7.5 Glucagon Like Peptide 2 Receptor Customers

8.1 Glucagon Like Peptide 2 Receptor Industry Trends

8.2 Glucagon Like Peptide 2 Receptor Market Drivers

8.3 Glucagon Like Peptide 2 Receptor Market Challenges

8.4 Glucagon Like Peptide 2 Receptor Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Glucagon Like Peptide 2 Receptor Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Glucagon Like Peptide 2 Receptor Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Glucagon Like Peptide 2 Receptor Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) of Key Manufacturers (2018-2023)

    Table 5. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Glucagon Like Peptide 2 Receptor Average Price (USD/Pcs) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Glucagon Like Peptide 2 Receptor, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Product Type & Application

    Table 12. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Like Peptide 2 Receptor as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Glucagon Like Peptide 2 Receptor Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Glucagon Like Peptide 2 Receptor Sales by Region (2018-2023) & (K Pcs)

    Table 18. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2018-2023)

    Table 19. Global Glucagon Like Peptide 2 Receptor Sales by Region (2024-2029) & (K Pcs)

    Table 20. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2024-2029)

    Table 21. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2018-2023)

    Table 23. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2024-2029)

    Table 25. North America Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Glucagon Like Peptide 2 Receptor Sales by Country (2018-2023) & (K Pcs)

    Table 27. North America Glucagon Like Peptide 2 Receptor Sales by Country (2024-2029) & (K Pcs)

    Table 28. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2018-2023) & (K Pcs)

    Table 32. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2024-2029) & (K Pcs)

    Table 33. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2018-2023) & (K Pcs)

    Table 37. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2024-2029) & (K Pcs)

    Table 38. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2018-2023) & (K Pcs)

    Table 42. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2024-2029) & (K Pcs)

    Table 43. Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales by Country (2018-2023) & (K Pcs)

    Table 47. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales by Country (2024-2029) & (K Pcs)

    Table 48. Middle East & Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2018-2023)

    Table 51. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2024-2029)

    Table 52. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2018-2023)

    Table 53. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2024-2029)

    Table 54. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2023)

    Table 57. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2024-2029)

    Table 58. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2018-2023)

    Table 59. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2024-2029)

    Table 60. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Application (2018-2023)

    Table 61. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Application (2024-2029)

    Table 62. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2018-2023)

    Table 63. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2024-2029)

    Table 64. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2023)

    Table 67. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2024-2029)

    Table 68. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2018-2023)

    Table 69. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2024-2029)

    Table 70. Hanmi Pharmaceuticals Co Ltd Corporation Information

    Table 71. Hanmi Pharmaceuticals Co Ltd Description and Business Overview

    Table 72. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 73. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product

    Table 74. Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates

    Table 75. Naia Ltd Corporation Information

    Table 76. Naia Ltd Description and Business Overview

    Table 77. Naia Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 78. Naia Ltd Glucagon Like Peptide 2 Receptor Product

    Table 79. Naia Ltd Recent Developments/Updates

    Table 80. Takeda Corporation Information

    Table 81. Takeda Description and Business Overview

    Table 82. Takeda Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 83. Takeda Glucagon Like Peptide 2 Receptor Product

    Table 84. Takeda Recent Developments/Updates

    Table 85. Tasly Pharmaceutical Group Co Ltd Corporation Information

    Table 86. Tasly Pharmaceutical Group Co Ltd Description and Business Overview

    Table 87. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 88. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product

    Table 89. Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates

    Table 90. Zealand Pharma AS Corporation Information

    Table 91. Zealand Pharma AS Description and Business Overview

    Table 92. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 93. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product

    Table 94. Zealand Pharma AS Recent Developments/Updates

    Table 95. Key Raw Materials Lists

    Table 96. Raw Materials Key Suppliers Lists

    Table 97. Glucagon Like Peptide 2 Receptor Distributors List

    Table 98. Glucagon Like Peptide 2 Receptor Customers List

    Table 99. Glucagon Like Peptide 2 Receptor Market Trends

    Table 100. Glucagon Like Peptide 2 Receptor Market Drivers

    Table 101. Glucagon Like Peptide 2 Receptor Market Challenges

    Table 102. Glucagon Like Peptide 2 Receptor Market Restraints

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Glucagon Like Peptide 2 Receptor

    Figure 2. Global Glucagon Like Peptide 2 Receptor Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Glucagon Like Peptide 2 Receptor Market Share by Type in 2022 & 2029

    Figure 4. FE-203799 Product Picture

    Figure 5. Glepaglutide Product Picture

    Figure 6. GXG-8 Product Picture

    Figure 7. HM-15910 Product Picture

    Figure 8. Others Product Picture

    Figure 9. Global Glucagon Like Peptide 2 Receptor Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Glucagon Like Peptide 2 Receptor Market Share by Application in 2022 & 2029

    Figure 11. Short Bowel Syndrome

    Figure 12. Diabetes

    Figure 13. Diarrhea

    Figure 14. Obesity

    Figure 15. Others

    Figure 16. Global Glucagon Like Peptide 2 Receptor Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Glucagon Like Peptide 2 Receptor Market Size (2018-2029) & (US$ Million)

    Figure 18. Global Glucagon Like Peptide 2 Receptor Sales (2018-2029) & (K Pcs)

    Figure 19. Global Glucagon Like Peptide 2 Receptor Average Price (USD/Pcs) & (2018-2029)

    Figure 20. Glucagon Like Peptide 2 Receptor Report Years Considered

    Figure 21. Glucagon Like Peptide 2 Receptor Sales Share by Manufacturers in 2022

    Figure 22. Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers in 2022

    Figure 23. The Global 5 and 10 Largest Glucagon Like Peptide 2 Receptor Players: Market Share by Revenue in 2022

    Figure 24. Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 25. Global Glucagon Like Peptide 2 Receptor Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 26. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2018-2029)

    Figure 27. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2018-2029)

    Figure 28. U.S. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Canada Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2018-2029)

    Figure 31. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2018-2029)

    Figure 32. Germany Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. France Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. U.K. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Italy Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Russia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2018-2029)

    Figure 38. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2018-2029)

    Figure 39. China Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Japan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. South Korea Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. India Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Australia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Taiwan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Indonesia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Thailand Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Malaysia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Philippines Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2018-2029)

    Figure 50. Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2018-2029)

    Figure 51. Mexico Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Brazil Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Argentina Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2018-2029)

    Figure 55. Middle East & Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2018-2029)

    Figure 56. Turkey Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Saudi Arabia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. UAE Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 59. Global Sales Market Share of Glucagon Like Peptide 2 Receptor by Type (2018-2029)

    Figure 60. Global Revenue Market Share of Glucagon Like Peptide 2 Receptor by Type (2018-2029)

    Figure 61. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2018-2029)

    Figure 62. Global Sales Market Share of Glucagon Like Peptide 2 Receptor by Application (2018-2029)

    Figure 63. Global Revenue Market Share of Glucagon Like Peptide 2 Receptor by Application (2018-2029)

    Figure 64. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2018-2029)

    Figure 65. Glucagon Like Peptide 2 Receptor Value Chain

    Figure 66. Glucagon Like Peptide 2 Receptor Production Process

    Figure 67. Channels of Distribution (Direct Vs Distribution)

    Figure 68. Distributors Profiles

    Figure 69. Bottom-up and Top-down Approaches for This Report

    Figure 70. Data Triangulation

    Figure 71. Key Executives Interviewed